Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FY 2001 user fee rates

Executive Summary

Drug applications requiring clinical data will cost $309,647, an 8.4% increase from $285,740 in FY 2000. Applications not requiring clinical data, and applications for supplements requiring clinical data, will cost half that amount: $154,823, up from $142,870 in FY 2000. FDA projects the receipt of 163.6 fee-paying full-application-equivalent submissions in FY 2001, 10.1 more than FY 2000's 153.5 estimated receipts. The agency incorporates an FY 2000 inflation adjustment of 3.81% into its FY 2001 user fee rate
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS037136

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel